Expression and Prognostic Role of Cyclin-Dependent Kinase 1 (cdc2) in Hepatocellular Carcinoma

Ito, Yasuhiro; Takeda, Tsutomu; Sakon, Masato; Monden, Morito; Tsujimoto, Masahiko; Matsuura, Nariaki
July 2000
Oncology;2000, Vol. 59 Issue 1, p68
Academic Journal
The expression of cyclin-dependent kinase 1 (cdc2), cyclin A and cyclin B1 was immunohistochemically studied in 101 hepatocellular carcinomas (HCC). cdc2 overexpression was directly related to advanced stage, portal invasion, intrahepatic metastasis, poor differentiation, high α-fetoprotein level, large size, high Ki-67 labeling index and poor prognosis. Cyclin A and B1 overexpression showed similar tendency to that of cdc2, but they were not recognized as independent prognostic factors by multivariate analysis. These findings suggest that cdc2 plays the most crucial role of the G2/M modulators in cell cycle progression and cell proliferation of HCC and significantly predicts the recurrence of this carcinoma.Copyright © 2000 S. Karger AG, Basel


Related Articles

  • CDK4.  // Encyclopedic Reference of Cancer;2001, p174 

    An encyclopedia entry for cyclin dependent kinase 4, which forms a complex with D-type cyclins to promote progression through early G1, is presented.

  • CDK Inhibitory Protein.  // Encyclopedic Reference of Cancer;2001, p174 

    An encyclopedia entry for CDK inhibitory protein, also known as cyclin-dependent kinase inhibitor is a protein that inhibits the activity of cyclin/CDK complexes, is presented.

  • Cyclin-dependent Kinase (CDK) Inhibitor.  // Encyclopedic Reference of Cancer;2001, p234 

    An encyclopedia entry for cyclin-dependent kinase (CDK) inhibitor is presented. It notes that the two groups of CDK inhibitor are the Cip/Kip family and the cyclin INK4 family.

  • G2/M Cyclins.  // Encyclopedic Reference of Cancer;2001, p364 

    A definition of the term "G2/M cyclins" is presented. It refers to one of the subfamilies of the cyclin family. The cyclin family can be divided into subfamilies depending on the time their associated-cyclin dependent kinase (CDK) activity peaks. The member of the G2/M cyclins are cyclins B1, B2...

  • Opposing effects of Ets and Id proteins on p16[supINK4a] expression during cellular senescence. Ohtani, Naoko; Zebedee, Zoe; Huot, Thomas J.G.; Stinson, Julie A.; Sugimoto, Masataka; Ohashi, Yasuhiro; Sharrocks, Andrew D.; Peters, Gordon; Hara, Eiji // Nature;2/22/2001, Vol. 409 Issue 6823, p1067 

    Focuses on a cyclin-dependent kinase inhibitor and its potential as a tumor suppressor. Demonstration of a role for the Ets1 and Ets2 transcription factors in the process; Implication of the kinase inhibitor in replicative senescence; Reference to the lifespan of human diploid fibroblasts.

  • Cyclin-Dependent Kinase Modulators Studied at the NCI: Pre-Clinical and Clinical Studies. Edward A. Sausville // Current Medicinal Chemistry - Anti-Cancer Agents;Jan2003, Vol. 3 Issue 1, p47 

    The cyclin dependent kinases (CDKs) are key regulators of cell cycle progression. Lead compounds (from empirical anti-proliferative screening approaches) have been defined which modulate CDK function and have evidence of anti-proliferative activity in tissue culture systems and in some cases...

  • Recent Patents on Cell Cycle Regulatory Proteins. Chulu, Julius L. C.; Liu, Hung J. // Recent Patents on Biotechnology;Jan2009, Vol. 3 Issue 1, p1 

    Cell cycle progression and cell division are driven by the sequential activation of a group of serine-threonine kinases called cyclin-dependent kinases (Cdks). Multiple Cdks control the cell cycle in mammals and have been long considered essential for normal proliferation, development and...

  • Studies of variations of the cyclin-dependent kinase inhibitor 1C and the cyclin-dependent kinase 4 genes in relation to type 2 diabetes mellitus and related quantitative traits. Nielsen, Eva-Maria; Hansen, Lars; Stissing, Trine; Yanagisawa, Keiko; Borch-Johnsen, Knut; Poulsen, Pernille; Vaag, Allan; Hansen, Torben; Pedersen, Oluf // Journal of Molecular Medicine;May2005, Vol. 83 Issue 5, p353 

    CDK4 is involved in the regulation of body weight, pancreatic ß-cell proliferation, insulin responsiveness, and diabetes pathogenesis. CDK4 activity is inhibited by CDKN1C, which is regulated by insulin. In addition, CDKN1C plays an important role in ß-cell proliferation and is involved in...

  • Indirubin-3′-monoxime inhibits autophosphorylation of FGFR1 and stimulates ERK1/2 activity via p38 MAPK. Zhen, Y.; Sørensen, V.; Jin, Y.; Suo, Z.; Więdłocha, A. // Oncogene;9/27/2007, Vol. 26 Issue 44, p6372 

    Indirubin-3′-monoxime is a derivative of the bis-indole alkaloid indirubin, an active ingredient of a traditional Chinese medical preparation that exhibits anti-inflammatory and anti-leukemic activities. Indirubin-3′-monoxime is mainly recognized as an inhibitor of cyclin-dependent...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics